Led by multiple-award winning equities researcher Russell Wright with over 25 years of industry experience, the research team provides the most extensive coverage of the ASX – covering the broadest spectrum of sectors by reviewing over 500 ASX-listed stocks and writing reports on over 200 stocks every year.

EverBlu’s research philosophy is based on analysing the fundamental value of a company – it means you look at the returns you’d expect to receive over the lifetime of ownership. By applying this same method to all stocks the unified valuation methodology allows stocks in different sectors to be readily compared.

quote

Don't wait for better Investment options, Invest and then wait for better time.

JOHN DOE, CHAIRMAN EVERBLU CAPITAL

Led by multiple-award winning equities researcher Russell Wright with over 25 years of industry experience, the research team provides the most extensive coverage of the ASX – covering the broadest spectrum of sectors by reviewing over 500 ASX-listed stocks and writing reports on over 200 stocks every year.

EverBlu’s research philosophy is based on analysing the fundamental value of a company – it means you look at the returns you’d expect to receive over the lifetime of ownership.  By applying this same method to all stocks the unified valuation methodology allows stocks in different sectors to be readily compared. 

Trust

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

01

Trust

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

02

Trust

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

03

Trust

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

04

Latest Research

Latest Capital Raise

CANNPAL ANIMAL THERAPEUTICS LIMITED – BUY – TARGET PRICE A$0.47

LEARN MORE

Latest Upcoming Capital raises for Australian companies in the past year

Research Expertise

Mr Wright has over 25 years’ experience in the financial services industry particularly in financial analysis and research report writing.
Mr Wright commenced at EverBlu Capital in 2017 as an Authorised Representative where he has been involved in the research and publication of reports.
Prior to this Mr Wright worked at a number of entities where he held Head of Research and Director of Research positions. Mr Wright holds a Bachelor of Mathematics (Honours) from Edinburgh University and an SDIA Accreditation Program RG146 from Deakin Prime.